Myeloma Clinical Trials

Multiple Myeloma Education Platform for Myeloma Community

[ASH @ASH_hematology]

Elevate your #ASH25 experience with the app! Log in using your ASH credentials to access your schedule and resources.

iOS: https://t.co/Fs9EsSzhrk

Android: https://t.co/U3IpPNCrSx

🌟New! Web app (no download required) https://t.co/Kt2x4CzcYb

#Hematology

[ASH @ASH_hematology]

The #ASH25 virtual platform is now live! Log in now using the ASH username and password you used to register for the annual meeting: https://t.co/3jw8qOrd7x

🌟Your bonus and preview content await. Plus, explore networking, exhibits, and more on the virtual platform!

[Rahul Banerjee, MD, FACP @RahulBanerjeeMD]

#IMS24 so excited to see this map of upcoming @Myeloma_Society #MMsm myeloma meetings!

Canada, Scotland, India, US, Finland, and Türkiye 🤩

Save the dates now!

[Vincent Rajkumar @VincentRK]

The International Myeloma Society (IMS) is a force. 21st Annual meeting in Rio opened yesterday with >2000 attendees!

The best new data and abstracts are here. @Myeloma_Society @NikhilMunshiMD @SagarLonialMD @szusmani @NoopurRajeMD @Mohty_EBMT

[Rahul Banerjee, MD, FACP @RahulBanerjeeMD]

Our brave new world of “quad-eligible” vs “quad-ineligible” in newly diagnosed myeloma regardless of ASCT is here 👏

Plus isa in 1st line as CD38 mAb… great news for #MMsm pts and congrats to IMROZ team! (And BENEFIT, IsKia, GMMG CONCEPT, & more!)

https://t.co/S7Fb9zQqMw

[Multiple Myeloma Hub @MM_Hub]

🚨 Only 2 weeks to go!

Join the #MultipleMyeloma Hub symposium at #ESHMM2024:

How to sequence BCMA-directed therapies in early relapsed/refractory MM

Chaired by @Mohty_EBMT, with guest speakers @DrRakeshPopat and @MyMKaiser

@ESHaematology #mmsm

[Multiple Myeloma RF @theMMRF]

Great news for NDMM patients: today, the @US_FDA approved Sarclisa (isatuximab) combined with Velcade, Revlimid, and dexamethasone (Isa-VRD) for transplant-ineligible patients with newly diagnosed multiple myeloma. https://t.co/T6A0MlnXjJ

[Suzanne Lentzsch, MD, PhD @SLentzsch]

FDA approves isatuximab-irfc with bortezomib, lenalidomide, and dexamethasone for newly diagnosed multiple myeloma https://t.co/0VdHSVQW1X

[International Myeloma Foundation @IMFmyeloma]

What can you do to help educate people about myeloma during #BloodCancerAwarenessMonth? Even something as small as leaving a like and comment or sharing a myeloma fact helps raise awareness. Try sharing this to your story. The IMF is grateful for you! #kNOwMyeloma

[International Myeloma Foundation @IMFmyeloma]

Wise words from our fearless leader, President and CEO of the IMF and 28-year myeloma survivor Yelak Biru @NorthTxMSG: "While you are trying to avoid dying, do not forget to live." What's something small you do to maintain your joie de vivre? #kNOwMyeloma #mmsm

[International Myeloma Foundation @IMFmyeloma]

The IMF is developing a simple blood test to replace painful bone marrow testing. How would this test enhance your quality of life? #kNOwMyeloma #BloodCancerAwarenessMonth Thank you @GSK for spreading #BloodCancerAwareness

[International Myeloma Foundation @IMFmyeloma]

Today, 9/20/24, the FDA has approved Sarclisa (isatuximab-irfc) with bortezomib, lenalidomide, and dexamethasone for newly diagnosed #multiplemyeloma. The IMF brings you the news at https://t.co/wPhr78KkLj

#mmsm

[Myeloma Society @Myeloma_Society]

Make sure you're part of the action at #IMS24! Don't let your colleagues have all the fun! Join us from September 25-28, either in Rio de Janeiro or virtually, for the 2024 IMS Annual Meeting. 🗓️ Secure your spot today: https://t.co/de54CRSCbG

[International Myeloma Foundation @IMFmyeloma]

May is #OncologyNursingMonth.
Thank you to the resilient #oncology #nurses everywhere and thank you to our IMF Nurse Leadership Board who lead the charge in advancing myeloma care and support. ❤️
#IMFNLB #NationalNursesMonth

[C. Ola Landgren, M.D. @DrOlaLandgren]

Discussion on MRD as an End Point for Multiple Myeloma Trials & Next Steps

https://t.co/RcgaaGmB8k via @targetedonc

#mmsm @theMMRF @HealthTree @IMFmyeloma @LLSusa @ASH_hematology @SylvesterCancer @univmiami

[International Myeloma Foundation @IMFmyeloma]

Join us for the keynote at the IMF Patient and Family Seminar in Boca Raton, FL on March 15-16, 2024! Dr. Saad Usmani, MD (Memorial Sloan Kettering Cancer Center, NY) will present on: What is the Future of Myeloma? Register: https://t.co/fXQh85lTTG

[Myeloma Clinical Trials @MMTrials]

Conclusion Remarks - FDA-IMS Joint Workshop - defining patient populations for #clinicaltrials #mmsm #MultipleMyeloma @US_FDA @FDAOncology @Myeloma_Society #curemyeloma

[Myeloma Clinical Trials @MMTrials]

Conclusion Remarks - FDA-IMS Joint Workshop - defining patient populations for #clinicaltrials #mmsm #MultipleMyeloma @US_FDA @FDAOncology @Myeloma_Society #curemyeloma

[Myeloma Clinical Trials @MMTrials]

Conclusion Remarks - FDA-IMS Joint Workshop - defining patient populations for #clinicaltrials #mmsm #MultipleMyeloma @US_FDA @FDAOncology @Myeloma_Society #curemyeloma

[Myeloma Clinical Trials @MMTrials]

Conclusion Remarks - FDA-IMS Joint Workshop - defining patient populations for #clinicaltrials #mmsm #MultipleMyeloma @US_FDA @FDAOncology @Myeloma_Society #curemyeloma